• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

构象受限的血管紧张素转换酶抑制剂的设计

Design of conformationally constrained angiotensin-converting enzyme inhibitors.

作者信息

Weller H N, Gordon E M, Rom M B, Pluscec J

出版信息

Biochem Biophys Res Commun. 1984 Nov 30;125(1):82-9. doi: 10.1016/s0006-291x(84)80337-x.

DOI:10.1016/s0006-291x(84)80337-x
PMID:6095846
Abstract

Modification of alanyl proline by introduction of both zinc coordinating and S1 subsite binding interactions affords potent new carboxy- and mercapto-acyl dipeptide angiotensin-converting enzyme (ACE) inhibitors. Design of these inhibitors was guided by an extension of the hypothetical ACE active site model originally used to derive captopril. Significant increases in ACE inhibitory activity were observed by introduction of conformation constraint into acyclic acyl dipeptides, thus further defining the three dimensional structure of the ACE active site.

摘要

通过引入锌配位和S1亚位点结合相互作用来修饰丙氨酰脯氨酸,可得到有效的新型羧基和巯基酰基二肽血管紧张素转换酶(ACE)抑制剂。这些抑制剂的设计以最初用于推导卡托普利的假设ACE活性位点模型的扩展为指导。通过在无环酰基二肽中引入构象限制,观察到ACE抑制活性显著增加,从而进一步确定了ACE活性位点的三维结构。

相似文献

1
Design of conformationally constrained angiotensin-converting enzyme inhibitors.构象受限的血管紧张素转换酶抑制剂的设计
Biochem Biophys Res Commun. 1984 Nov 30;125(1):82-9. doi: 10.1016/s0006-291x(84)80337-x.
2
Cyclic (hydroxyphosphinyl)acyl dipeptides: a new class of angiotensin converting enzyme inhibitors.环状(羟基亚膦酰基)酰基二肽:一类新型血管紧张素转换酶抑制剂。
J Enzyme Inhib. 1988;2(3):183-98. doi: 10.3109/14756368809040725.
3
Inhibition of angiotensin-converting enzyme by dipeptide analogs.
Res Commun Chem Pathol Pharmacol. 1984 Sep;45(3):339-45.
4
Inhibition of rabbit lung angiotensin-converting enzyme by N alpha-[(S)-1-carboxy-3-phenylpropyl]L-alanyl-L-proline and N alpha-[(S)-1-carboxy-3-phenylpropyl]L-lysyl-L-proline.Nα-[(S)-1-羧基-3-苯基丙基] -L-丙氨酰-L-脯氨酸和Nα-[(S)-1-羧基-3-苯基丙基] -L-赖氨酰-L-脯氨酸对兔肺血管紧张素转换酶的抑制作用
J Biol Chem. 1985 Mar 10;260(5):2952-62.
5
Recent developments in the design of angiotensin-converting enzyme inhibitors.
Med Res Rev. 1985 Oct-Dec;5(4):483-531. doi: 10.1002/med.2610050405.
6
New potent inhibitors of angiotensin converting enzyme.
FEBS Lett. 1984 Jan 9;165(2):201-6. doi: 10.1016/0014-5793(84)80169-6.
7
Optimal recognition of neutral endopeptidase and angiotensin-converting enzyme active sites by mercaptoacyldipeptides as a means to design potent dual inhibitors.巯基酰二肽对中性内肽酶和血管紧张素转换酶活性位点的最佳识别:一种设计强效双重抑制剂的方法
J Med Chem. 1996 Mar 15;39(6):1210-9. doi: 10.1021/jm950590p.
8
Ketomethyldipeptides I. A new class of angiotensin converting enzyme inhibitors.
Biochem Biophys Res Commun. 1984 Oct 15;124(1):141-7. doi: 10.1016/0006-291x(84)90928-8.
9
Effect of peptide-based captopril analogues on angiotensin converting enzyme activity and peroxynitrite-mediated tyrosine nitration.基于肽的卡托普利类似物对血管紧张素转换酶活性和过氧亚硝酸盐介导的酪氨酸硝化的影响。
Org Biomol Chem. 2011 Jul 21;9(14):5185-92. doi: 10.1039/c1ob05148b. Epub 2011 May 31.
10
Design of orally active dual inhibitors of neutral endopeptidase and angiotensin-converting enzyme with long duration of action.具有长效作用的口服活性中性内肽酶和血管紧张素转换酶双重抑制剂的设计
J Med Chem. 1996 Jun 21;39(13):2594-608. doi: 10.1021/jm950783c.

引用本文的文献

1
Small molecule angiotensin converting enzyme inhibitors: A medicinal chemistry perspective.小分子血管紧张素转换酶抑制剂:药物化学视角
Front Pharmacol. 2022 Nov 1;13:968104. doi: 10.3389/fphar.2022.968104. eCollection 2022.
2
QXP: powerful, rapid computer algorithms for structure-based drug design.QXP:用于基于结构的药物设计的强大、快速计算机算法。
J Comput Aided Mol Des. 1997 Jul;11(4):333-44. doi: 10.1023/a:1007907728892.